The peptide market is flooded with cheap powder and cheaper promises. Here is the short list of companies where the price is real, the sourcing is traceable, and you are not gambling with your health to save fifty bucks.
Why Budget Peptides Are Tricky Right Now
Early 2026 was rough for this space. The FDA sent warning letters to more than thirty compounding and telehealth companies over how they marketed compounded GLP-1 drugs. A settlement between Novo Nordisk and some of the biggest telehealth names pushed several platforms away from compounded semaglutide entirely. Prices shifted, catalogs shrank, and a lot of formerly “affordable” options quietly became expensive branded prescriptions with thin clinical support.
That shakeout actually clarified things. The companies that held up are the ones worth knowing.
1. FormBlends
The only source on this list offering both GLP-1 peptides and a full research-grade catalog under one clinician-supervised roof. That combination is genuinely rare.
Here is how it works. You complete an online intake, a licensed physician reviews it, and your order is dispensed through an FDA-registered compounding pharmacy. Coverage runs to 47 states, and cold-chain handling is built into the shipping at no extra charge. No separate membership fee stacked on top of the medication cost.
The pricing is public before you commit. Compounded semaglutide runs $299 per vial. Tirzepatide is $349. For the broader peptide catalog: BPC-157 is $54, TB-500 is $49, and the BPC/TB combination vial comes in at $79. Those are not introductory teaser prices that balloon on month two. They are the prices.
What earns my confidence on quality is the batch testing. Every lot goes through three independent lab checks covering purity, identity, and sterility. The numbers for individual products are published openly, not buried in a generic one-page certificate. Semaglutide purity clocks at 99.1 percent. BPC-157 hits 99.2. Most peptide sellers either cannot show you that data or wave a single certificate at you that covers an entire product line without specifics.
Worth being clear about something: compounded medications have not gone through the FDA’s drug approval process. For the non-GLP-1 peptides, most of the human evidence is still early-stage or preclinical. FormBlends does not pretend otherwise, and neither will I.
2. Mochi Health
If your primary goal is weight loss and you want someone with real obesity medicine credentials reviewing your case, Mochi stands out. The clinical team is board-certified in obesity medicine, not just general telehealth practitioners ticking a box.
Compounded semaglutide is roughly $99 per month. Compounded tirzepatide runs around $199. Commit to three or twelve months and the per-month cost drops further. They also accept insurance for branded medications when compounded options are not appropriate, so the path from budget-friendly access to long-term management is reasonably clear.
The monitoring is more attentive than you get at lighter-touch platforms. For weight loss specifically, that actually matters.
3. MEDVi
Simple structure. No contracts, no recurring membership fee baked into the cost before you even see a medication price. Compounded GLP-1 access starts at about $179 for the first month, physician review is included, and they advertise 24/7 support access.
I put MEDVi here because the no-contract model is genuinely useful for people who want to try a program without locking into an annual commitment. Some of the bigger platforms make it uncomfortable to leave. MEDVi does not.
4. Sesame (Success by Sesame)
Sesame’s core model is a marketplace, which means pricing is unusually transparent. The Success by Sesame subscription runs from about $59 per month on an annual plan. That covers telehealth visits and unlimited messaging. Medication is billed separately, which can feel inconvenient, but it also means you are not hiding a $200 drug cost inside a $300 “program fee.”
They prescribe branded, FDA-approved medications rather than compounded ones. For patients who want Ozempic or Wegovy with actual insurance adjudication, Sesame’s approach is cleaner than most.
Short. Direct. Low friction. Not glamorous, but the pricing math holds up.
5. Henry Meds
Speed matters to some people. Henry Meds consistently gets compounded medications out the door fast, often within 24 to 72 hours of approval. Month-one pricing typically lands between $179 and $249, depending on the medication.
The tradeoff is depth of clinical oversight. Henry Meds is lighter on ongoing monitoring compared to something like Mochi. If you are self-directed, understand what you are taking, and primarily need access and fast fulfillment, that tradeoff may be perfectly acceptable. If you want regular clinical touchpoints, you will probably want a platform with heavier infrastructure.
One Thing All Five Get Right
None of these bury the real cost behind a sign-up wall. In a market where “starting at $X” frequently means “plus membership, plus shipping, plus medication,” that transparency is not trivial.
For the non-GLP-1 peptides specifically, remember that much of the research base is animal studies and small human trials. “Available” does not mean “proven.” Before adjusting any protocol involving prescription or compounded medications, run it by a qualified clinician who knows your full health picture. Not a form on a website. An actual conversation.
Sources
- FDA.gov (compounding pharmacy regulations, 503A guidelines, 2026 warning letters to telehealth companies)
- GoodRx (branded GLP-1 pricing reference)
- Examine.com (peptide and GLP-1 research summaries)
- Drugs.com (medication information and compounding context)
- Verywell Health (GLP-1 drug comparison coverage)
- Cleveland Clinic (weight management specialist guidance and GLP-1 prescribing standards)
- Healthline (telehealth platform comparisons, 2025-2026)
[internal: placement #1 | structure: Tight curated list, opinionated picks]
